D.R. Horton, Inc.’s Stock Price Soars to $156.09, Marking a Significant 3.02% Upsurge

D.R. Horton, Inc. (DHI)

156.09 USD +4.58 (+3.02%) Volume: 2.92M

D.R. Horton, Inc.’s stock price is currently performing robustly at 156.09 USD, marking a positive trading session with a percentage change of +3.02%. The company’s stock, with a trading volume of 2.92M, has also shown a promising year-to-date progress with a +2.70% increase, indicating a healthy investment opportunity.

Latest developments on D.R. Horton, Inc.

D.R. Horton Inc. experienced significant stock price movements today, outperforming competitors on a strong trading day and attracting considerable attention from investors. Diversified Trust Co acquired 866 shares, while Peak Financial Advisors LLC purchased 18,186 shares. B. Riley Wealth Advisors Inc. added 2500 shares to their portfolio, and Exchange Traded Concepts LLC and Greenhaven Associates Inc. also increased their shareholdings. However, DNB Asset Management AS reduced their stock position, and director Allen Barbara K sold shares worth over $30k. Despite these movements, questions remain about whether D.R. Horton stock is a buy.

D.R. Horton, Inc. on Smartkarma

Smartkarma, an independent investment research network, has recently seen an increase in analyst coverage for Dr Horton Inc, a company that specializes in homebuilding. One of the recent reports published on Smartkarma is from Business Breakdowns, featuring a podcast episode with Ed Wachenheim, founder of Greenhaven Capital. In the podcast, Wachenheim shares his insights on the history, business model, and competitive advantages of Dr. Horton, as well as his investment approach. This report, sourced from publicly available information, offers valuable insights for investors interested in the homebuilding industry.

Another report on Smartkarma comes from Baptista Research, who have initiated coverage on Dr Horton Inc. This is the first report from Baptista Research on the company, and it highlights the company’s solid first quarter results for the fiscal year 2024. The report also mentions a promising increase in net sales orders by 35% from the previous year’s quarter. Baptista Research also dives into the company’s ingenious tactics to overcome soaring costs and skyrocket profits, making it a valuable read for anyone interested in Dr Horton Inc.

A look at D.R. Horton, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

D.R. Horton, Inc. is a company that builds and sells single-family homes. They focus on homes for people who are just starting out or looking to upgrade. They operate in different regions of the United States, including the Midwest, Mid-Atlantic, Southeast, Southwest, and Western regions. On top of building homes, they also offer financial services like mortgage financing and title agency services for homebuyers.

Looking at the long-term outlook for D.R. Horton Inc, the Smartkarma Smart Scores give us a good indication of how the company may perform in the future. With a score of 3 for value, it suggests that the company’s stock may be priced fairly and could potentially offer good value for investors. The company also scores a 2 for dividend, which means they may not offer a high dividend yield, but it could still be a good option for those looking for some steady income. With high scores of 4 for growth, resilience, and momentum, it seems that D.R. Horton Inc is in a strong position to continue growing and weather any potential challenges in the market. Overall, the Smart Scores give a positive outlook for the company’s future performance.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma